MedTrace Logo

HeartLinc, a Study With AMI Patients Undergoing PCI

NCT03322436 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2024-05-23

No results posted yet for this study

Summary

HeartLinc is a non-interventional patient study to demonstrate medical utility of the lncRNA to predict HF in AMI patients. 300 patients are expected to be recruited.

Conditions

  • AMI Patients

Interventions

DIAGNOSTIC_TEST

HeartLinc kit

Samples are collected and analyzed afterwards

Sponsors & Collaborators

  • Firalis SA

    lead INDUSTRY

Principal Investigators

  • Hüseyin FIRAT, MD, PhD, · Firalis SA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-13
Primary Completion
2022-07-30
Completion
2022-10-31

Countries

  • France
  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03322436 on ClinicalTrials.gov